Literature DB >> 3871098

Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome.

A Winkelstein, R S Klein, T L Evans, B W Dixon, W L Holder, L D Weaver.   

Abstract

Depressed T cell immunity is a universal characteristic of the acquired immunodeficiency syndrome (AIDS). In the present study, 25 patients with AIDS and opportunistic infections, 22 individuals with AIDS-related complex (ARC, or chronic lymphadenopathy syndrome), and 20 healthy homosexuals were evaluated by means of the T cell colony assay. Forty-seven healthy heterosexual controls showed an average of 3964 +/- 319 colonies/7.5 X 10(5) cells, with a range of 880 to 9340. The mean in the 20 healthy homosexuals (3173 +/- 483) did not differ significantly from the controls; in this group, only three patients had values less than 1000 colonies/plate. By contrast, all AIDS patients and 14 ARC patients had colony counts less than 1000. The mean value for the AIDS patients was only 24 +/- 15 (p less than 0.0005 compared with either controls or healthy homosexuals); values in the ARC group were intermediate (1180 +/- 360). The addition of interleukin 2 to the plates promoted correction of the proliferative abnormality in ARC patients. This interleukin increased colony scores in the AIDS group, but the mean value was still significantly less than controls. Comparison indicated that the colony assay is a more sensitive indicator for detecting proliferative abnormalities than responses to PHA, Con A, or pokeweed mitogen in suspension cultures.

Entities:  

Mesh:

Year:  1985        PMID: 3871098

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection.

Authors:  A Winkelstein; L A Kingsley; R S Klein; D W Lyter; T L Evans; C R Rinaldo; L D Weaver; L L Machen; R C Schadle
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 2.  Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.

Authors:  M Allouche; Y Lunardi-Iskandar; C Varela-Millot; M Itzhaki; P Cornuet; P Meyer; C Jasmin; V Georgoulias
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.

Authors:  Y Lunardi-Iskandar; M T Nugeyre; V Georgoulias; F Barré-Sinoussi; C Jasmin; J C Chermann
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

5.  Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells.

Authors:  J B Margolick; D J Volkman; H C Lane; A S Fauci
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS).

Authors:  E M Levy; J C Beldekas; K H Mayer; P H Black
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

7.  Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.

Authors:  H W Murray; K Welte; J L Jacobs; B Y Rubin; R Mertelsmann; R B Roberts
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC.

Authors:  J Wu; E M Levy; P H Black
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

9.  Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).

Authors:  M Ernst; P Kern; H D Flad; A J Ulmer
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

10.  Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.

Authors:  Y Lunardi-Iskandar; A Gessain; V H Lam; R C Gallo
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.